CARsgen wins world-first CAR T-cell approval for solid tumours
June 23, 2026 | 11:56
CARsgen Therapeutics announced that China's NMPA has approved Satri-cel, marking the world's first CAR T-cell therapy product approved for solid tumours.
Mobile Version